GSD announces multiple new products to aid COVID-19 pandemic

 In News

 

Gold Standard Diagnostics announces multiple new products for the serologic detection of Antibodies in patients having been exposed to COVID 19

Gold Standard Diagnostics Inc and its affiliates Virotech Diagnostics GmbH and Novatec Immundiagnostica GmbH are announcing multiple product launches to support healthcare authorities in their fight against Covid-19.

The first ELISA assays are expected to receive CE-IVD mark by April 16th and will also be available in the US as an IVD.

Multiple solutions to support health authorities in their fight against COVID-19

A comprehensive product portfolio is essential to support the tremendous efforts of health authorities working on SARS-CoV-2 detection and COVID 19 control all over the world. During the last 6 weeks, in close collaboration with leading research hospitals and laboratories around the world, our teams worked diligently to offer a broad range of testing methods to healthcare providers around the world.

The following products will be released shortly to leading reference centers and hospitals around the world:

  • Serology – Antibody tests for IgG, IgM, and IgA will be released for use on any open ELISA platform.
  • Lateral Flow – As additional option with fast turnaround time, an easy-to-use rapid lateral flow antibodies test is under final development and validation.
  • Automation – Gold Standard Diagnostics offers a suite of instruments for the seamless automation of assay testing in any laboratory.

If you have any questions, please reach out to a GSD representative for more information or email ussales@gsdx.us.

 

 

 ABOUT GOLD STANDARD DIAGNOSTICS, CORP.

 Gold Standard Diagnostics, Corp. is a clinical diagnostics company based in Davis, California. The company develops, manufactures and distributes a portfolio of instrumentation and diagnostic test kits to clinical laboratories around worldwide. In addition to the AIX1000, current product offerings include the Thunderbolt and Bolt®, open format instrumentation platforms for enzyme and chemiluminescence immunoassays, and an extensive menu of serology tests across autoimmune, infectious, and endocrine diseases.  Gold Standard Diagnostics is a member of the Eurofins group of companies.

 

Recent Posts